Ferroptosis
Ferroptosis is a unique iron-dependent form of nonapoptotic cell death. It is triggered by oncogenic RAS-selective lethal small molecule erastin. Acitvation of ferroptosis lead to nonapoptotic destruction of cancer cells.
Products Related to Ferroptosis(211)
- GC15681Liproxstatin-1CAS: 950455-15-9Purity: >98.00%
Liproxstatin-1 is a highly efficient and selective ferroptosis inhibitor with an IC 50 of 22nM.
- GC16444RosiglitazoneCAS: 122320-73-4Purity: >98.00%
Rosiglitazone is an orally active peroxisome proliferator-activated receptor gamma (PPARγ) selective agonist that selectively activates chimeras containing the PPARγ ligand-binding domain (LBD) but not PPARα and PPARδ with an EC 50 of 60 nM and a K d of 40nM.
- GC17309Withaferin ACAS: 5119-48-2Purity: >98.00%
Withaferin A is a steroidal lactone generally obtained from Withania somnifera (L.) Dunal, commonly known as Ashwagandha.
- GC18089Nordihydroguaiaretic acidCAS: 500-38-9Purity: >97.00%
Nordihydroguaiaretic acid is a potent 5-lipoxygenase (5-LOX) inhibitor with an IC 50 value of 8μM.
- GC19936Quisinostat dihydrochlorideCAS: 875320-31-3Purity: >98%
Quisinostat dihydrochloride (JNJ-26481585 dihydrochloride) is an orally available, potent pan-HDAC inhibitor with IC50s of 0.11 nM, 0.33 nM, 0.64 nM, 0.46 nM, and 0.37 nM for HDAC1, HDAC2, HDAC4, HDAC10 and HDAC11, respectively. Quisinostat dihydrochloride has a broad spectrum antitumoral activity.
- GC20109Cefotiam hexetil hydrochlorideCAS: 95789-30-3Purity: >98%
Cefotiam hexetil hydrochloride (CTM-HE) is an oral third-generation cephalosporin, which is a prodrug of cefotiam, but has no anti-bacterial property. Cefotiam is an antibiotic.
- GC26219NCOA4 - 9aCAS: 2650557-72-3Purity: >98.00%
NCOA4 - 9a is an inhibitor of ferritinophagy that inhibits erastin-induced ferroptosis, with an EC 50 value of 0.29μM.
- GC30067Butylhydroxyanisole (Butylated hydroxyanisole)CAS: 25013-16-5Purity: >99.00%
Butylhydroxyanisole (Butylated hydroxyanisole) (Butylated hydroxyanisole) is an antioxidant used as a food additive preservative.
| Catalog No. | Product Name | CAS No. | Purity | Structure |
|---|---|---|---|---|
| GC15541 | Fluvastatin Sodium | 93957-55-2 | >98.00% | |
An HMG-CoA reductase inhibitor | ||||
| GC15681 | Liproxstatin-1 | 950455-15-9 | >98.00% | |
Liproxstatin-1 is a highly efficient and selective ferroptosis inhibitor with an IC 50 of 22nM. | ||||
| GC15972 | Idebenone | 58186-27-9 | >99.50% | |
synthetic analog of coenzyme Q10 (CoQ10) | ||||
| GC16014 | Zileuton | 111406-87-2 | >99.00% | |
Zileuton, a benzothiophene N-hydroxyurea, is an oral inhibitor of 5-Lipoxygenase. | ||||
| GC16444 | Rosiglitazone | 122320-73-4 | >98.00% | |
Rosiglitazone is an orally active peroxisome proliferator-activated receptor gamma (PPARγ) selective agonist that selectively activates chimeras containing the PPARγ ligand-binding domain (LBD) but not PPARα and PPARδ with an EC 50 of 60 nM and a K d of 40nM. | ||||
| GC16517 | Eugenol | 97-53-0 | >98.00% | |
naturally occuring scent chemical | ||||
| GC16630 | Erastin | 571203-78-6 | >98.00% | |
Erastin is a ferroptosis activator. | ||||
| GC16733 | Vildagliptin (LAF-237) | 274901-16-5 | >98.00% | |
A DPP-4 inhibitor | ||||
| GC16868 | Sulfasalazine | 599-79-1 | >98.00% | |
Sulfasalazine is a sulfonamide drug. | ||||
| GC17309 | Withaferin A | 5119-48-2 | >98.00% | |
Withaferin A is a steroidal lactone generally obtained from Withania somnifera (L.) Dunal, commonly known as Ashwagandha. | ||||
| GC17369 | Sorafenib | 284461-73-0 | >98.00% | |
Sorafenib acts as a multi-kinase inhibitor, targeting Raf-1 and B-Raf with IC 50 values of 6 nM and 22 nM, respectively. | ||||
| GC17412 | Deferasirox Fe3+ chelate | 554435-83-5 | >98.00% | |
| GC17498 | L-Glutamine | 56-85-9 | >98.00% | |
Non-essential amino acid | ||||
| GC18089 | Nordihydroguaiaretic acid | 500-38-9 | >97.00% | |
Nordihydroguaiaretic acid is a potent 5-lipoxygenase (5-LOX) inhibitor with an IC 50 value of 8μM. | ||||
| GC18101 | Deferiprone | 30652-11-0 | >98.00% | |
Chelating agent | ||||
| GC18705 | ML-210 | 1360705-96-9 | >98.00% | |
ML-210 is a prodrug that selectively inhibits GPX4 covalently with an EC 50 of 30nM. | ||||
| GC19254 | ML385 | 846557-71-9 | >98.00% | |
ML385 is a cell-active NRF2 inhibitor (IC 50 =1.9μM). | ||||
| GC19457 | Trolox | 53188-07-1 | >98.00% | |
Trolox is a cell-permeable, water-soluble derivative of vitamin E with potent antioxidant properties. | ||||
| GC19706 | Propacetamol hydrochloride | 66532-86-3 | >98% | |
| GC19936 | Quisinostat dihydrochloride | 875320-31-3 | >98% | |
Quisinostat dihydrochloride (JNJ-26481585 dihydrochloride) is an orally available, potent pan-HDAC inhibitor with IC50s of 0.11 nM, 0.33 nM, 0.64 nM, 0.46 nM, and 0.37 nM for HDAC1, HDAC2, HDAC4, HDAC10 and HDAC11, respectively. Quisinostat dihydrochloride has a broad spectrum antitumoral activity. | ||||
| GC20109 | Cefotiam hexetil hydrochloride | 95789-30-3 | >98% | |
Cefotiam hexetil hydrochloride (CTM-HE) is an oral third-generation cephalosporin, which is a prodrug of cefotiam, but has no anti-bacterial property. Cefotiam is an antibiotic. | ||||
| GC26219 | NCOA4 - 9a | 2650557-72-3 | >98.00% | |
NCOA4 - 9a is an inhibitor of ferritinophagy that inhibits erastin-induced ferroptosis, with an EC 50 value of 0.29μM. | ||||
| GC30039 | FIN56 | 1083162-61-1 | >98.00% | |
FIN56, a novel ferroptosis inducer, triggers ferroptosis by increasing the degradation of GPX4 . | ||||
| GC30067 | Butylhydroxyanisole (Butylated hydroxyanisole) | 25013-16-5 | >99.00% | |
Butylhydroxyanisole (Butylated hydroxyanisole) (Butylated hydroxyanisole) is an antioxidant used as a food additive preservative. | ||||
